108985 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on peptide bonds (3.4); Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals Aspartic endopeptidases (3.4.23)
Aspartic Protease, Methods and Uses Thereof
#2SYSTEMS AND METHODS FOR INHIBITING gamma-SECRETASE PRODUCTION OF AMYLOID-beta PEPTIDES
#3Animal Model With Rapid Onset Of Alzheimer's Amyloid Beta Plaque Pathology
#4GENE THERAPY FOR NEURODEGENERATIVE DISORDERS USING POLYNUCLEOTIDE SILENCING AND REPLACEMENT
#5METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#6Systems and methods for inhibiting γ-secretase production of amyloid-β peptides
#7METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#8GENE THERAPY FOR ALZHEIMER`S DISEASE
#9Stabilization of chymosin by polymers
#10ASPARTIC PROTEASES
#11Method of manufacturing membrane protein and utilization thereof
#12METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#13BACE1 inhibitor peptides
#14Expression sequences
#15METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#16Stabilization of chymosin by polymers
#17IMPROVED PURIFICATION OF PROTEINS VIA A DEGLYCOSYLATION STEP
#18Expression sequences
#19Truncated secretory aspartyl proteinase 2
#20Nematode-Resistant Transgenic Plants
#21Human lysosomal protein and methods of its use
#22Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor
#23Polypeptides having aspartic endopeptidase activity and polynucleotides encoding same
#24BETA-SECRETASE ENZYME COMPOSITIONS AND METHODS
#25Truncated secretory aspartyl proteinase 2
#26COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
#27LIQUID COMPOSITION COMPRISING AN ASPARTIC PROTEASE
#28Glycosylation variants of BACE
#29BIOLOGICAL ENTITIES AND THE USE THEREOF
#30BIOLOGICAL ENTITIES AND THE USE THEREOF
#31AGENTS FOR PRE-SYMPTOMATIC DETECTION AND THERAPEUTIC TARGETING OF ALZHEIMER'S DISEASE AND DOWN SYNDROME IN HUMANS
#32Use of aspartic proteases in cosmetics and therapeutics
#33Methods of using crystals of beta amyloid cleaving enzyme (BACE)
#34Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof
#35Beta-secretase enzyme compositions and methods
#36Method of producing catalytically active BACE2 enzymes
#37Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#38Human lysosomal protein and methods of its use
#39Method of Screening Transmembrane Enzyme Inhibitory Substance
#40Inhibitors of Taspase1 protease activity
#41Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#42Catalytically active recombinant memapsin and methods of use thereof
#43Method of expressing human lysosomal protein in brain cells
#44Inhibitors of Memapsin 2 and use thereof
#45Beta secretase genes
#46Metastatic breast and colon cancer regulated genes
#47Beta secretase polypeptides
#48Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme
#49Human Protease Molecules
#50Method of identifying/designing and/or modifying chemical species capable of interacting with a physiologically active macromolecule
#51Method of screening compounds
#52Universal procedure for refolding recombinant proteins
#53ASP2
#54ASP2
#55Cathepsin-associated genetically modified nonhuman mammal
#56Use of aspartic proteases in cosmetics and therapeutics
#57Novel beta-secretase and modulation of beta-secretase activity
#58Methods for the identification of compounds for the treatment of Alzheimer's disease
#59Method of producing an aspartic protease in a recombinant host organism
#60Modified BACE
#61Tap-70, a novel marker for epithelial tumors
#62Taspase1 and methods of use
#63Human protease molecules
#64β-secretase enzyme compositions and methods
#65Alzheimer's disease secretase, APP substrates thereof, and uses thereof
#66Methods for detecting expression of human protease molecules
#67Beta-secretase enzyme compositions and methods
#68Beta-secretase enzyme compositions and methods
#69Beta-secretase enzyme compositions and methods
#70β-secretase enzyme compositions and methods
#71ASP2
#72Alzheimer's disease secretase, app substrates therefor, and uses therefor
#73Constructs for homogenously processed preparations of beta site APP-cleaving enzyme
#74Gamma three protease
#75Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
#76Engineered enzymes and uses thereof
#77Alzheimer's disease secretase